Cargando…

Postanesthetic Severe Oral Angioedema in Patient's Taking Angiotensin-Converting Enzyme Inhibitor

Angiotensin-converting enzyme (ACE) inhibitors are the leading cause of a drug-induced angioedema. This occurrence is frequently underdiagnosed, but its relapse can be life-threatening. The authors' intention in reporting this clinical case is to sound a warning about reviewing attitudes and su...

Descripción completa

Detalles Bibliográficos
Autores principales: Marques, Acílio, Retroz-Marques, Carla, Mota, Sara, Cabral, Raquel, Campos, Matos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241279/
https://www.ncbi.nlm.nih.gov/pubmed/25431681
http://dx.doi.org/10.1155/2014/693191
_version_ 1782345829518934016
author Marques, Acílio
Retroz-Marques, Carla
Mota, Sara
Cabral, Raquel
Campos, Matos
author_facet Marques, Acílio
Retroz-Marques, Carla
Mota, Sara
Cabral, Raquel
Campos, Matos
author_sort Marques, Acílio
collection PubMed
description Angiotensin-converting enzyme (ACE) inhibitors are the leading cause of a drug-induced angioedema. This occurrence is frequently underdiagnosed, but its relapse can be life-threatening. The authors' intention in reporting this clinical case is to sound a warning about reviewing attitudes and surveillance to try to improve patient perioperative safety.
format Online
Article
Text
id pubmed-4241279
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-42412792014-11-27 Postanesthetic Severe Oral Angioedema in Patient's Taking Angiotensin-Converting Enzyme Inhibitor Marques, Acílio Retroz-Marques, Carla Mota, Sara Cabral, Raquel Campos, Matos Case Rep Anesthesiol Case Report Angiotensin-converting enzyme (ACE) inhibitors are the leading cause of a drug-induced angioedema. This occurrence is frequently underdiagnosed, but its relapse can be life-threatening. The authors' intention in reporting this clinical case is to sound a warning about reviewing attitudes and surveillance to try to improve patient perioperative safety. Hindawi Publishing Corporation 2014 2014-11-06 /pmc/articles/PMC4241279/ /pubmed/25431681 http://dx.doi.org/10.1155/2014/693191 Text en Copyright © 2014 Acílio Marques et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Marques, Acílio
Retroz-Marques, Carla
Mota, Sara
Cabral, Raquel
Campos, Matos
Postanesthetic Severe Oral Angioedema in Patient's Taking Angiotensin-Converting Enzyme Inhibitor
title Postanesthetic Severe Oral Angioedema in Patient's Taking Angiotensin-Converting Enzyme Inhibitor
title_full Postanesthetic Severe Oral Angioedema in Patient's Taking Angiotensin-Converting Enzyme Inhibitor
title_fullStr Postanesthetic Severe Oral Angioedema in Patient's Taking Angiotensin-Converting Enzyme Inhibitor
title_full_unstemmed Postanesthetic Severe Oral Angioedema in Patient's Taking Angiotensin-Converting Enzyme Inhibitor
title_short Postanesthetic Severe Oral Angioedema in Patient's Taking Angiotensin-Converting Enzyme Inhibitor
title_sort postanesthetic severe oral angioedema in patient's taking angiotensin-converting enzyme inhibitor
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241279/
https://www.ncbi.nlm.nih.gov/pubmed/25431681
http://dx.doi.org/10.1155/2014/693191
work_keys_str_mv AT marquesacilio postanestheticsevereoralangioedemainpatientstakingangiotensinconvertingenzymeinhibitor
AT retrozmarquescarla postanestheticsevereoralangioedemainpatientstakingangiotensinconvertingenzymeinhibitor
AT motasara postanestheticsevereoralangioedemainpatientstakingangiotensinconvertingenzymeinhibitor
AT cabralraquel postanestheticsevereoralangioedemainpatientstakingangiotensinconvertingenzymeinhibitor
AT camposmatos postanestheticsevereoralangioedemainpatientstakingangiotensinconvertingenzymeinhibitor